HT31-1

· HTIC, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HT31-1, covering 2026-03-04 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HT31-1 for Treating ARDS [Phase 1]